← Back to all signals
ELV · Q2 2026

Elevance Health, Inc.

Reported 2026-07-15
BEAT
45EarnIQ signal

Confidence rising

Mild quarter-over-quarter shift

Solid second-quarter beat and raised full-year guidance reinforce confidence in long-term earnings growth.

  • Guidance was raised, with high specificity.
  • Management tone registered as confident (80/100).
  • EarnIQ detected 0 potential management deflections.
Headline–confidence gap

Headline confirmed

Management confidence reinforces the reported beat.

EPS: reported vs expected+18.9%$7.45 vs $6.27
Revenue: reported vs expected— vs —
Guidance specificityHighRaised
Market expectations supplied by Finnhub · Reported vs consensus estimate

We are raising our 2026 adjusted EPS guidance to at least $27.00 and accelerating targeted investments in the capabilities that matter most.

EarnIQ Premium

Understand exactly why confidence changed.

Unlock management-language evidence, guidance specificity, the pressure point, narrative breaks, risks, and quarter-over-quarter topic changes.

Guidance specificityPressure pointNarrative breakSource evidence
Preview full report